PUBLISHER: The Business Research Company | PRODUCT CODE: 1947069
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947069
Respiratory devices and equipment, which encompass both therapeutic and diagnostic tools, play a vital role in providing medical assistance to individuals facing breathing difficulties and those unable to maintain sufficient oxygen levels to sustain life. These devices are essential for patients with respiratory disorders such as asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome (ARDS).
The primary categories of respiratory devices and equipment consist of diagnostic devices, therapeutic devices, and monitoring devices. Diagnostic devices are utilized to identify and diagnose respiratory-related conditions. Therapeutic devices include a range of equipment like humidifiers, nebulizers, oxygen concentrators, positive airway pressure (PAP) devices, ventilators, and more. Diagnostic devices encompass spirometers, polysomnography tools, and peak flow meters, while monitoring devices include pulse oximeters, capnography equipment, and gas analyzers. These devices find applications in various respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, obstructive sleep apnea (OSA), respiratory distress syndrome (RDS), cystic fibrosis, and pneumonia. They are utilized across healthcare settings, including hospitals, clinics, home care environments, and ambulatory service centers.
Tariffs are impacting the respiratory devices and equipment (therapeutic and diagnostic) market by increasing costs of imported ventilators, oxygen concentrators, sensors, control electronics, and monitoring components. Hospitals and homecare providers in North America and Europe are most affected due to dependence on imported respiratory equipment, while Asia-Pacific faces higher manufacturing and distribution costs. These tariffs are increasing device prices and slowing replacement cycles. However, they are also encouraging domestic production, regional supply chain diversification, and innovation in affordable respiratory care technologies.
The respiratory devices and equipment (therapeutic and diagnostic) market research report is one of a series of new reports from The Business Research Company that provides respiratory devices and equipment (therapeutic and diagnostic) market statistics, including respiratory devices and equipment (therapeutic and diagnostic) industry global market size, regional shares, competitors with a respiratory devices and equipment (therapeutic and diagnostic) market share, detailed respiratory devices and equipment (therapeutic and diagnostic) market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory devices and equipment (therapeutic and diagnostic) industry. This respiratory devices and equipment (therapeutic and diagnostic) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The respiratory devices and equipment (therapeutic and diagnostic) market size has grown rapidly in recent years. It will grow from $13.62 billion in 2025 to $15.34 billion in 2026 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to increasing prevalence of chronic respiratory disorders, expansion of hospital respiratory care units, rising demand for long-term oxygen therapy, improvements in ventilator technology, growing use of non-invasive respiratory support.
The respiratory devices and equipment (therapeutic and diagnostic) market size is expected to see rapid growth in the next few years. It will grow to $27.1 billion in 2030 at a compound annual growth rate (CAGR) of 15.3%. The growth in the forecast period can be attributed to growing demand for homecare respiratory solutions, increasing adoption of connected respiratory devices, expansion of tele-respiratory care services, rising investments in advanced ventilatory technologies, continued focus on patient-centric respiratory management. Major trends in the forecast period include increasing adoption of integrated diagnostic and therapeutic respiratory systems, rising deployment of home-based respiratory care devices, growing use of smart ventilation and oxygen therapy equipment, expansion of continuous respiratory monitoring solutions, enhanced focus on chronic respiratory disease management.
The rising prevalence of various respiratory diseases is anticipated to drive the growth of the respiratory devices and equipment (therapeutic and diagnostic) market in the coming years. Respiratory diseases are medical conditions that affect the lungs and airways, disrupting normal breathing and oxygen exchange due to inflammation, infection, obstruction, or chronic structural damage. The increasing prevalence of respiratory diseases is attributed to a growing global burden of conditions that progressively reduce lung function and increase susceptibility to long-term respiratory complications. Respiratory devices and equipment support the management of these diseases by improving airflow, enhancing oxygen delivery, and enabling more effective monitoring of lung function to help stabilize patient health. For example, in June 2025, according to the World Health Organization, a Switzerland-based organization, 81.7 million people are living with chronic respiratory diseases, and 6.8 million new cases are diagnosed each year. Therefore, the growing prevalence of respiratory diseases is contributing to the expansion of the respiratory devices and equipment (therapeutic and diagnostic) market.
Major companies in the respiratory devices and equipment (therapeutic and diagnostic) market are innovating with new technological products, such as the VitaloPFT series, to enhance their market profitability. The VitaloPFT Series comprises a range of pulmonary function testing devices. For example, in March 2023, Vitalograph Ltd., a US-based respiratory medical device company, introduced the respiratory VitaloPFT series. This series is designed to offer high-quality, accurate, and reliable respiratory medical equipment and services, primarily intended for use in secondary care. Hospitals and other secondary care facilities seeking advanced respiratory diagnostic solutions can benefit from the VitaloPFT Series.
In June 2023, SunMed Group Holdings, LLC, a Canada-based manufacturer and distributor of consumable medical devices for anesthesia and respiratory care, acquired the Respiratory Health business of Avanos Medical, Inc. for $110 million. Through this acquisition, SunMed seeks to enhance its respiratory care consumables portfolio by incorporating Avanos's well-established BALLARD, MICROCUFF, and endOclear product lines. Avanos is a US-based medical device company recognized for its respiratory consumables and catheter products.
Major companies operating in the respiratory devices and equipment (therapeutic and diagnostic) market are Smiths Medical Inc., Philips Healthcare, GE Healthcare, Chart Industries Inc., Invacare Corporation, Fisher & Paykel Healthcare Limited, ResMed Inc., Koninklijke Philips N.V., Dragerwerk AG, Medtronic plc, Masimo Corp., CareFusion Corporation, Compumedics Limited, Becton Dickinson and Company, Hamilton Medical, Mindray Medical International Limited, Vyaire Medical Inc., Getinge AB, AirSep Corporation, Breas Medical AB, Hill-Rom Holdings Inc., Inogen, Shenzhen Mindray Bio-Medical Electronics Co., Linde plc, DeVilbiss Healthcare LLC, Nihon Kohden Corporation, Nonin Medical Inc., O2 Concepts LLC, Precision Medical Inc., Pulmodyne Inc., Salter Labs Inc., Sechrist Industries Inc., Teleflex Inc., Ventec Life Systems, VitalAire, Weinmann Emergency Medical Technology GmbH + Co. KG, ZOLL Medical Corporation
Asia-Pacific was the largest region in respiratory devices and equipment (therapeutic and diagnostic) market in 2025. Western Europe was the second-largest region in respiratory devices and equipment (therapeutic and diagnostic) market. The regions covered in the respiratory devices and equipment (therapeutic and diagnostic) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the respiratory devices and equipment (therapeutic and diagnostic) market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The respiratory devices and equipment (therapeutic and diagnostic) market consists of sales of instruments such as humidifiers, nebulizers, oxygen concentrators, positive airway pressure (PAP) devices, ventilators, spirometer, polysomnographs, peak flow meters, pulse oximeters, capnographs, and gas analyzers. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses respiratory devices and equipment (therapeutic and diagnostic) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for respiratory devices and equipment (therapeutic and diagnostic) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The respiratory devices and equipment (therapeutic and diagnostic) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.